Previous 10 | Next 10 |
Newest health system collaboration gives Hims & Hers customers in Connecticut a trusted destination for access to high-quality healthcare services Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, and Connecticut...
2024-01-10 06:24:47 ET Summary Hims & Hers Health exhibits impressive revenue growth, defying market predictions in 2022 & 2023. The company operates as a versatile tele-health platform, offering a range of healthcare services and personalized treatment plans. Despite ...
2024-01-08 19:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-04 12:43:30 ET More on Him & Hers, LifeMD, etc. Hims & Hers Health: Faultless, Ready To Go Higher Hims & Hers: New Weight Loss Category Is A Prescription For Explosive Growth And Upward Revisions Hims & Hers Health: Promising Catalysts To Driv...
2024-01-02 08:46:00 ET People can and should consider what Wall Street analysts say about a stock. After all, these analysts are the professionals of the investing world and are compensated very well for their research and opinions. But that doesn't mean that they're always right. In fa...
2023-12-19 02:00:00 ET Summary Hims & Hers has been a poor performer, as it wasn't as profitable as many investors had hoped. Despite investor hesitation, the stock is undervalued, priced at 30x its estimated 2025 free cash flow, with no debt. The company's strong revenue ...
2023-12-18 06:38:36 ET Summary Hims & Hers is a fast-growing telehealth company with a focus on subscriptions and prescriptions for chronic conditions. The company's expansion into the weight loss drugs category significantly increases its total addressable market and will dri...
2023-12-17 19:03:12 ET Summary Hims & Hers Health has reported strong quarterly results and improved profits, leading to a stock snapback. The company is moving into AI-based medical services and weight loss management to address soaring costs. The stock is incredibly chea...
2023-12-14 12:15:13 ET Summary Hims & Hers Health raised its guidance once again when it reported its Q3 results. The company saw significant growth in subscribers, particularly in the mental health and women's health sectors. HIMS is one of the cheapest growth stocks arou...
2023-12-13 13:37:28 ET More on AmWell, Teladoc, etc. Teladoc: High Stock Compensation Is An Issue Teladoc: No Floor Yet Teladoc's Valuation Proposition: 7x EBITDA In 2024, Not So Bad Global telemedicine market to hit $450B in 2032: report American Wel...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...